Not selling last week to save five percent on long term gains was a smart move. We already exceeded the five percent today, and if we sold today we would effectively realize the same or better gain despite the higher tax, but that long term gain tax isn't due until April 15th, 2014, not 2013. By that time, I would expect that the stock will be worth quite a lot more than it is today, likely over 30. Selling some shares at 25 would have been a good move for those who needed the money, but not at 19 as many retailers last week did because of fiscal cliff fears combined with the five percent increase in the gains tax. Expectations of a weak launch for ponatinib are baked into the current share price. Any good news now will be reflected in a higher stock price. I believe we have seen the bottom, and this stock should start to ascend now.
